EA202091961A1 - EXTRACELLULAR VESICULES CONTAINING AGONIST STING - Google Patents
EXTRACELLULAR VESICULES CONTAINING AGONIST STINGInfo
- Publication number
- EA202091961A1 EA202091961A1 EA202091961A EA202091961A EA202091961A1 EA 202091961 A1 EA202091961 A1 EA 202091961A1 EA 202091961 A EA202091961 A EA 202091961A EA 202091961 A EA202091961 A EA 202091961A EA 202091961 A1 EA202091961 A1 EA 202091961A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- vesicules
- extracellular
- immune response
- present
- sting agonists
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
В настоящем изобретении предложены композиции, содержащие ВВ, например экзосому, с инкапсулированными агонистами STING, и способы получения описанных композиций. В настоящем изобретении также предложены способы модулирования иммунного ответа посредством введения терапевтического количества ВВ, например экзосом, с инкапсулированными агонистами STING. Иммунный ответ может представлять собой ответ IFN- или активацию миелоидных дендритных клеток (мДК). В настоящем изобретении также предложены способы модулирования иммунного ответа, не индуцирующего системное воспаление, посредством введения экзосом с инкапсулированными агонистами STING.The present invention provides compositions containing an explosive, eg an exosome, with encapsulated STING agonists, and methods for preparing the disclosed compositions. The present invention also provides methods for modulating the immune response by administering a therapeutic amount of BBs, eg exosomes, with encapsulated STING agonists. The immune response can be an IFN-γ response or activation of myeloid dendritic cells (mDC). The present invention also provides methods for modulating an immune response that does not induce systemic inflammation by administering exosomes with encapsulated STING agonists.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962822019P | 2019-03-21 | 2019-03-21 | |
PCT/US2019/023727 WO2019183578A1 (en) | 2018-03-23 | 2019-03-22 | Extracellular vesicles comprising sting-agonist |
Publications (1)
Publication Number | Publication Date |
---|---|
EA202091961A1 true EA202091961A1 (en) | 2021-02-20 |
Family
ID=74855490
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA202091961A EA202091961A1 (en) | 2019-03-21 | 2019-03-22 | EXTRACELLULAR VESICULES CONTAINING AGONIST STING |
Country Status (1)
Country | Link |
---|---|
EA (1) | EA202091961A1 (en) |
-
2019
- 2019-03-22 EA EA202091961A patent/EA202091961A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2020013046A2 (en) | Extracellular vesicles comprising sting agonist | |
EA201992131A1 (en) | HIGH-AFFINE SPECIFIC TO MAGE-A1 TCR AND THEIR APPLICATION | |
EA202191975A2 (en) | THERAPEUTIC DELIVERY DEVICE | |
MX2019012819A (en) | Bis 2'-5'-rr-(3'f-a)(3'f-a) cyclic dinucleotide compound and uses thereof. | |
NI201900112A (en) | STABLE FORMULATIONS OF ANTIBODIES AGAINST PROGRAMMED DEATH RECEIVER 1 (PD-1) AND METHODS FOR THEIR USE. | |
PH12020500500A1 (en) | Pyrazolopyrimidinone compounds and uses thereof | |
EA202090919A1 (en) | Lipid Nanoparticles for the Delivery of Modified RNA Encoding VEGF-A POLYPEPTIDE | |
PH12020551436A1 (en) | Intracellular delivery of biomolecules to modify immune response | |
MX2020007697A (en) | Pharmaceutical compositions comprising bispecific antibodies directed against cd3 and cd20 and their uses. | |
PH12019500365A1 (en) | Highly concentrated low viscosity masp-2 inhibitory antibody formulations, kits, and methods | |
MX2019000566A (en) | Ev-mediated delivery of binding protein-small molecule conjugates. | |
TN2018000443A1 (en) | Stable liquid pharmaceutical preparation | |
WO2018115003A3 (en) | Novel tnfr agonists and uses thereof | |
MX2021013657A (en) | Antibody drug conjugates. | |
WO2018081531A3 (en) | Methods for human t-cell activation | |
MX2017016418A (en) | Long acting liraglutide compositions. | |
ZA202107825B (en) | Pharmaceutical parenteral composition of dual glp1/2 agonist | |
MX2021004331A (en) | Stable semaglutide compositions and uses thereof. | |
MA38975A1 (en) | Intrauterine delivery device | |
EA202091961A1 (en) | EXTRACELLULAR VESICULES CONTAINING AGONIST STING | |
MX2018011149A (en) | Extended release conjugates of exenatide analogs. | |
AR115013A1 (en) | EXTRACELLULAR VESICLE INCLUDING STING'S AGONIST | |
EA201992883A1 (en) | ANTIBODIES TO TrkB | |
WO2021041822A8 (en) | Methods of increasing vaccine efficacy | |
EA202191308A1 (en) | DISPOSABLE CASSETTE ASSEMBLY |